BidaskClub Upgrades Mylan N.V. (MYL) to Hold
Mylan N.V. (NASDAQ:MYL) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Tuesday.
Several other analysts also recently weighed in on MYL. Cowen and Company restated a “hold” rating and set a $30.00 target price (down from $43.00) on shares of Mylan N.V. in a research note on Wednesday, August 9th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $32.00 price target (down previously from $33.00) on shares of Mylan N.V. in a research note on Thursday, August 10th. Citigroup Inc. upgraded Mylan N.V. from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $36.00 to $42.00 in a research note on Wednesday, August 16th. Cantor Fitzgerald set a $34.00 price target on Mylan N.V. and gave the stock a “hold” rating in a research note on Wednesday, August 9th. Finally, Wells Fargo & Company set a $30.00 price target on Mylan N.V. and gave the company a “hold” rating in a report on Wednesday, August 9th. One analyst has rated the stock with a sell rating, nine have given a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $42.46.
Shares of Mylan N.V. (MYL) traded up 0.43% during midday trading on Tuesday, hitting $32.53. The stock had a trading volume of 4,166,479 shares. Mylan N.V. has a one year low of $29.39 and a one year high of $45.87. The company has a market cap of $17.45 billion, a P/E ratio of 26.30 and a beta of 1.30. The stock has a 50 day moving average of $31.43 and a 200-day moving average of $36.46.
Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by ($0.08). Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same period last year, the firm earned $1.16 EPS. The business’s quarterly revenue was up 15.7% on a year-over-year basis. Analysts forecast that Mylan N.V. will post $4.52 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently modified their holdings of MYL. Global X Management Co. LLC boosted its stake in Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock valued at $118,000 after acquiring an additional 1,441 shares during the period. TLP Group LLC acquired a new stake in shares of Mylan N.V. during the 1st quarter worth approximately $200,000. Doliver Capital Advisors LP acquired a new stake in shares of Mylan N.V. during the 2nd quarter worth approximately $201,000. Eagle Global Advisors LLC acquired a new stake in shares of Mylan N.V. during the 2nd quarter worth approximately $205,000. Finally, Sheaff Brock Investment Advisors LLC acquired a new stake in shares of Mylan N.V. during the 2nd quarter worth approximately $210,000. 71.97% of the stock is currently owned by hedge funds and other institutional investors.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.